Medical specialists from United Kingdom tagged as investigators in clinical trials studying Monoclonal Gammopathy of Undetermined Significance
Total 1 results
-
Karthik RamasamySeen in:
- England, Oxford, Oxford University Hospitals NHS Foundation Trust
- Oxford., GSK Investigational Site
- Oxfordshire, Oxford, Secure Study
Trials:- NCT05539079 (Principal Investigator)
- NCT03215030 (Principal Investigator)
- NCT05714839 (Principal Investigator)
Conditions:
Clinical Trials on Monoclonal Gammopathy of Undetermined Significance
-
RxCelerate LtdRxCelerate LimitedUnknownMonoclonal Gammopathy of Unknown SignificanceUnited Kingdom
-
Dartmouth-Hitchcock Medical CenterCelgene CorporationTerminatedNeuropathy | Nonmalignant Monoclonal Gammopathy of Undetermined Significance (MGUS)United States
-
University of Milano BicoccaCompletedMonoclonal Gammopathy of Renal SignificanceItaly
-
Rennes University HospitalCompletedMyeloma | Monoclonal Gammopathy | Monoclonal Gammopathy of Undetermined SignificationFrance
-
Academia Nacional de MedicinaUnknownMonoclonal Gammopathy of Renal SignificanceArgentina
-
UMC UtrechtBeiGeneNot yet recruitingMonoclonal Gammopathy of Uncertain SignificanceNetherlands
-
Columbia UniversityGenzyme, a Sanofi CompanyRecruitingMonoclonal GammopathyUnited States
-
Regeneron PharmaceuticalsNot yet recruitingMonoclonal Gammopathy of Undetermined Significance (MGUS) | Smoldering Multiple Myeloma (SMM)
-
Peking University People's HospitalRecruitingMonoclonal Gammopathy of Renal SignificanceChina
-
Oxford University Hospitals NHS TrustRecruiting